Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor

Citation
J. Nigou et al., Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor, J IMMUNOL, 166(12), 2001, pp. 7477-7485
Citations number
53
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
166
Issue
12
Year of publication
2001
Pages
7477 - 7485
Database
ISI
SICI code
0022-1767(20010615)166:12<7477:MLIIPB>2.0.ZU;2-K
Abstract
IL-12 is a key cytokine in directing the development of type I Th cells, wh ich are critical to eradicate intracellular pathogens such as Mycobacterium tuberculosis. Here, we report that mannose-capped lipoarabinomarmans (ManL AMs) from Mycobacterium bovis bacillus Calmette-Guerin and Mycobacterium tu berculosis inhibited, in a dose-dependant manner, the LPS-induced IL-12 pro duction by human dendritic cells. The inhibitory activity was abolished by the loss of the mannose caps or the GPI acyl residues. Mannan, which is a l igand for the mannose receptor (MR) as well as an mAb specific for the MR, also inhibited the LPS-Induced IL-12 production by dendritic cells. Our res ults indicate that ManLAMs may act as virulence factors that contribute to the persistence of M. bovis bacillus Calmette-Guerin and M. tuberculosis wi thin phagocytic cells by suppressing IL-12 responses. Our data also suggest that engagement of the MR by ManLAMs delivers a negative signal that inter feres with the LPS-induced positive signals delivered by the Toll-like rece ptors.